RecruitingPhase 4NCT06118905

Preserving Geriatric Muscle With an Osteoporosis Medication

Sponsor

Susan L. Greenspan

Enrollment

155 participants

Start Date

Feb 8, 2024

Study Type

INTERVENTIONAL

Conditions

Osteoporosis

Summary

Our goal is to demonstrate efficacy of the novel agent Denosumab to improve or preserve muscle health, strength, mobility and function in frail older adults.

Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Denosumab 60 MG/ML and a drug called Zoledronic Acid 5Mg/Bag 100Ml Infusion for people with osteoporosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.